Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SlovakiaBack to Slovakia

Clinical trials in Martin

93 clinical trials in Martin, Slovakia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Martin at a glance
93
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

93 trials in Martin

Open in trial search

Renal disorder

Recruiting
InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.

Primary progressive multiple sclerosis

Recruiting
InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

Focal segmental glomerulosclerosis

Recruiting
InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting
Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Empasiprubart
  • Sponsor:Argenx

Bronchiectasis

Recruiting
InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Acute respiratory failure

Recruiting
InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Conjunctivitis allergic

Recruiting
Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:0–17 years
  • Substances:Desloratadine
  • Sponsor:Allergy Therapeutics (UK) Limited

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Recruiting
InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Type 2 diabetes mellitus

Recruiting
Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB

Systemic lupus erythematosus

Recruiting
InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International

Colitis ulcerative

Recruiting
Investigational
Countries:SlovakiaSlovakia
  • Participants:0–17 years
  • Substances:Etrasimod Arginine
  • Sponsor:Pfizer Inc.

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting
InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Empasiprubart
  • Sponsor:Argenx

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Martin

What the registry says about research in the country

01 Respiratory Medicine

Innovative research focusing on chronic obstructive pulmonary disease (COPD) and severe viral lung infections. Clinical trials are evaluating new treatments to reduce exacerbations and improve patient outcomes.

  • COPD Management
  • Viral Lung Infections
  • Respiratory Support Therapies

Studies are exploring advanced therapeutic options for patients requiring supplemental oxygen and ventilatory support.

02 Autoimmune Disorders

Comprehensive research into multiple autoimmune conditions, including multiple sclerosis, Sjögren's syndrome, and systemic lupus erythematosus. Trials focus on novel biological therapies.

  • Multiple Sclerosis Treatment
  • Lupus Management
  • Inflammatory Conditions

Investigations aim to improve disease control and quality of life for patients with chronic autoimmune conditions.

03 Dermatology

Advanced research in skin conditions, particularly atopic dermatitis and hidradenitis suppurativa. Studies evaluate combination therapies with topical corticosteroids and novel systemic treatments.

  • Eczema Management
  • Inflammatory Skin Conditions
  • Long-term Treatment Strategies

Focus on developing flexible dosing regimens and long-term management solutions for chronic skin conditions.

Back to SlovakiaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

ClinicalTrials.eu

Every clinical trial in Europe, in plain language.

Explore the full ecosystem of clinical research in Europe.

Search trials

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).